Approval · Notice of Compliance 3155 · 1998
VALTREX: Notice of Compliance 3155
Issued December 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3155
- Date
- December 4, 1998
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional indication for the suppression of recurrent genital herpes and for a new tablet strength
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALTREX | 02239130 | — |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 250 MG per TAB